Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer

Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is one of the most lethal tumors generally and the most fatal cancer of the female genital tract. The approved standard therapy consists of surgical cytoreduction and platinum/taxane-based chemotherapy, and of targeted therapy in selected patients. The main t...

Full description

Bibliographic Details
Main Authors: Jacek Wilczyński, Edyta Paradowska, Justyna Wilczyńska, Miłosz Wilczyński
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Current Oncology
Subjects:
ovarian cancer
prediction
biomarkers
chemoresistance
Online Access:https://www.mdpi.com/1718-7729/31/1/15

Internet

https://www.mdpi.com/1718-7729/31/1/15

Similar Items